Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2018 Nov 16;13(11):e0207402.
doi: 10.1371/journal.pone.0207402. eCollection 2018.

Serodiscordant partnerships and opportunities for pre-exposure prophylaxis among partners of women and men living with HIV in St. Petersburg, Russia

Natalia Gnatienko  1 , Jennifer A Wagman  2 , Debbie M Cheng  3 , Angela R Bazzi  4 , Anita Raj  2 , Elena Blokhina  5 , Olga Toussova  5 , Leah S Forman  6 , Dmitry Lioznov  7   8 , Carly Bridden  1 , Meg Sullivan  9 , Kendall Bryant  10 , Jeffrey H Samet  4   11 , Judith I Tsui  12
Affiliations
Clinical Trial

Serodiscordant partnerships and opportunities for pre-exposure prophylaxis among partners of women and men living with HIV in St. Petersburg, Russia

Natalia Gnatienko et al. PLoS One. .

Abstract

Objective: To describe the frequency of being partnered and having an HIV-negative partner, and whether this differed by gender, among a cohort of persons living with HIV (PLWH) who have ever injected drugs; to describe awareness of HIV pre-exposure prophylaxis (PrEP) and perceived partner interest in PrEP.

Setting: Secondary analyses of an observational cohort study of PLWH who have ever injected drugs in St. Petersburg, Russia.

Methods: Primary outcomes were 1) being partnered and 2) being in a serodiscordant partnership. The main independent variable was gender. Multivariable GEE logistic regression models were fit for binary outcomes, adjusted for age, income, education, and recent opioid use. Descriptive analyses were performed for partners' HIV status, substance use, sex risk behaviors, and awareness of PrEP for a subset of participants.

Results: At baseline, 50% (147/296) reported being in a partnership, and of those, 35% were in a serodiscordant partnership. After adjustment, women had significantly higher odds of being partnered compared to men (aOR = 3.12; 95% CI: 1.77, 5.51), but there were no significant gender differences in the odds of being in a serodiscordant partnership (aOR = 0.58; 95% CI: 0.27, 1.24). Among a sub-sample of participants queried (n = 56), 25% were aware of PrEP for prevention of sexual HIV transmission and 14% for prevention of injection-related transmission.

Conclusion: Although half of our sample were partnered and one third of these partnerships were serodiscordant, PrEP awareness was low. Substantial opportunities for HIV prevention exist among PLWH who have ever injected drugs in Russia and their HIV-negative partners. Given the high proportion of HIV-negative partners among this ART-naïve sample, efforts to address the associated inherent risks, such as couples-based interventions, are needed to increase condom use, PrEP awareness, or uptake of other HIV-prevention modalities (e.g., ART for the HIV-positive partner).

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

References

    1. UNAIDS. Global AIDS Update 2018. 2018.
    1. UN Joint Programme on HIV/AIDS (UNAIDS). The Gap Report. 2014.
    1. European Centre for Disease Prevention and Control/ WHO Regional Office for Europe. HIV/AIDS Surveillance in Europe 2015. 2016.
    1. Federal Scientific Center for the Prevention and Combat of AIDS of the Public Office of the Central Scientific Research Institute Rospotrebnadzor. Reference on HIV infection in the Russian Federation as of June 30, 2017. Available at: https://protect-us.mimecast.com/s/Pa7UCrk5X4cpxEJS7PPBY?domain=hiv65.ru. Accessed June 14, 2018.
    1. Beyrer C, Wirtz AL, O'Hara G, Leon N, Kazatchkine M. The expanding epidemic of HIV-1 in the Russian Federation. PLoS Med 2017. November 28;14(11):e1002462 10.1371/journal.pmed.1002462 - DOI - PMC - PubMed

Publication types